PATENT CLAIM ANALYSIS

Application Number: 15940158
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["435", "007100"]

Abstract:
Certain embodiments are directed to marker peptides or marker peptide antibodies can be used in producing diagnostic kits or used in diagnostic methods for Alzheimer's disease. The antibodies and/or marker peptides can be used in immunohistochemical and biochemical methods for qualitative and quantitative analysis of marker peptide levels and/or localization in brain samples and CSF samples.

Claim (Index 11):
The kit according to  claim 9 , wherein the marker peptide is coupled to a support.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.59459
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['09980881', '14810760', '15342629', '13582308', '15207836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.623537800987584
- 35 USC 102 Novelty (BERT): 0.5271846094445239
- Combined Prediction Score: 0.6139024818332781
- Mean Citation Score: 332.7754740000001
- Max Citation Score: 346.69672
- Similarity Product: 224.66009516331675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test